Gyrodyne, LLC $GYRO
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Opeators of Nonresidential Buildings
- Headquarters
- St. James, NY
- Fiscal year end
- December 31
- Shares outstanding
- 2,199,308 [10-Q 2026-08-13]
What the company doesAI summary of filing
Gyrodyne, LLC is a real estate company that owns and manages a portfolio of medical office and industrial properties located in Suffolk County (Flowerfield in St. James) and Westchester County (Cortlandt Manor) in New York. The company generates revenue through long-term leases on these properties, with tenants typically reimbursing the company for utilities, insurance, repairs, maintenance, and real estate taxes. Gyrodyne is pursuing entitlements and zoning approvals on both properties to increase their development flexibility and value, with the goal of selling all real estate assets and liquidating the company by the end of 2028, after which it will distribute remaining proceeds to shareholders. The company is currently revenue-generating but operating under a planned liquidation strategy. [10-K 2026-03-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 8 months to Aug 2015 | $1.83M | −$2.50M | −$2.29M | $7.47M | [10-K 2016-03-30] |
| FY ended Dec 2014 | $2.80M | −$3.11M | −$5.47M | $4.03M | [10-K 2016-03-30] |
- Quarterly cash burn
- −$860.2K
- Cash runway Estimate
- ~26 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-19 | 2,199,308 | [10-Q 2024-11-19] |
| 2025-03-28 | 2,199,308 | [10-K 2025-03-28] |
| 2025-05-05 | 2,199,308 | [10-Q 2025-05-05] |
| 2025-08-08 | 2,199,308 | [10-Q 2025-08-08] |
| 2025-11-10 | 2,199,308 | [10-Q 2025-11-10] |
| 2026-03-30 | 2,199,308 | [10-K 2026-03-27] |
| 2026-05-13 | 2,199,308 | [10-Q 2026-05-13] |
| 2026-08-13 | 2,199,308 | [10-Q 2026-08-13] |
- Shelf registration
- S-1 filed 2023-12-29; declared effective 2024-02-02 [S-1 2023-12-29]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-05 | DEF 14A | Proxy statement |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-07 | 8-K | Director or officer change |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-03-27 | 10-K | Annual report |
| 2026-01-12 | 8-K | Material agreement entered |
| 2025-11-10 | 10-Q | Quarterly report |
| 2025-11-07 | 8-K | Shareholder vote results |
| 2025-11-05 | 8-K | Regulation FD disclosure |
| 2025-10-20 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2025-10-17 | DEF 14A | Proxy statement |
| 2025-10-17 | 8-K | Material agreement entered; Other events |
Alerts for $GYRO
Email me when Gyrodyne, LLC files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.